SOP
Sophia Genetics
Stock
Stock
ISIN: CH1125843347
Ticker: SOPH
CH1125843347
SOPH
Price
Price
Frequently asked questions
What is Sophia Genetics's market capitalization?
The market capitalization of Sophia Genetics is $207.95M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Sophia Genetics?
Sophia Genetics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.087. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sophia Genetics's stock?
Currently, 5 analysts cover Sophia Genetics's stock, with a consensus target price of $8.667. Analyst ratings provide insights into the stock's expected performance.
What is Sophia Genetics's revenue over the trailing twelve months?
Over the trailing twelve months, Sophia Genetics reported a revenue of $64.49M.
What is the EBITDA for Sophia Genetics?
Sophia Genetics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$59.78M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sophia Genetics?
Sophia Genetics has a free cash flow of -$52.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Sophia Genetics's stock?
The 5-year beta for Sophia Genetics is 0.99. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Sophia Genetics have, and what sector and industry does it belong to?
Sophia Genetics employs approximately 449 people. It operates in the Information Technology sector, specifically within the Software & Programming industry.
What is the free float of Sophia Genetics's shares?
The free float of Sophia Genetics is 62.57M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$207.95M5Y beta
0.99EPS (TTM)
-$1.087Free Float
62.57MRevenue (TTM)
$64.49MEBITDA (TTM)
-$59.78MFree Cashflow (TTM)
-$52.00MPricing
1D span
$3.125$3.162
52W span
$2.70$7.37
Analyst Ratings
The price target is $8.667 and the stock is covered by 5 analysts.
Buy
3
Hold
2
Sell
0
Information
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
449
Software & Programming
Information Technology
Identifier
ISIN
CH1125843347
Primary Ticker
SOPH